MiBA Announces Key Leadership Team Appointment

TAMPA, Florida, March 7, 2025 – Meaningful Insights Biotech Analytics (MiBA) is pleased to announce the appointment of Matt Hagan as Vice President of Marketing and Client Innovation. With over 27 years of experience in biopharmaceutical marketing and commercial roles, Matt brings extensive industry knowledge and expertise to MiBA. His distinguished career has focused on marketing innovative hematology and oncology therapies for leading biopharma companies, including Cellectar, Bristol Myers Squibb, Celgene, and AMAG Pharmaceuticals.

"We are absolutely thrilled to welcome Matt to our leadership team as we continue to rapidly grow our organizational capabilities with world-class experts in biopharma marketing, health economics outcomes research, and clinical research," said Jason Baroff, Managing Partner. He added, "His wealth of knowledge in launching and marketing pharmaceuticals in the hematology/oncology space will be invaluable as MiBA expands its innovative solutions portfolio."

In his new role, Mr. Hagan will spearhead efforts to enhance and expand MiBA's biopharma solution offerings, leveraging the company's intelligent platforms that deliver industry-leading accuracy and diverse data insights for healthcare partners. This appointment aligns with MiBA's strategic growth objectives in the rapidly evolving biotech analytics sector.

About MiBA

MiBA is the premier source for oncology insights, offering the industry's most accurate and diverse data to revolutionize clinical decision-making. With unmatched speed and actionable insights, MiBA transforms cancer research and patient care.

For more information, please visit www.mibanalytics.com or join the conversation by following us on LinkedIn.

### 

Media Relations 

Contact: Theresa Boxberger 
pr@l7creative.com 
T: 800-572-7888 
E: PR@L7creative.com 
www.mibanalytics.com